논문KCI 등재
MASLD after hepatitis C virus eradication: Do not overlook the cardiometabolic risk factors: Editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (15)
관련 논문AI추천
Metabolic dysfunction in patients following DAAinduced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Chen-Hua Liu, Yu-Ping Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Jae Young Jang, Seung Up Kim, Tom Ryu, Young Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct- acting antiviral therapy: A multicenter study for chronic hepatitis C”Chen-Hua Liu, Yu-Ping Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in TaiwanChao-Kuan Huang, Chia-Yen Dai, Chih-Wen Wang, Chung-Feng Huang, Jee-Fu Huang, Ming-Lung Yu, Ming-Lun Yeh, Ming-Yen Hsieh, Pei-Chien Tsai, Po-Cheng Liang, Tyng-Yuan Jang, Tzu-Chun Lin, Wan-Long Chuang, Yi-Hung Lin, Yu-Ju Wei대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”Chia-Yen Dai, Chung-Feng Huang, Jee-Fu Huang, Ming-Lung Yu, Ming-Lun Yeh, Wan-Long Chuang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Metabolic health in antiviral era of chronic hepatitis B: Editorial on “Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues”Jia-Horng Kao, Shang-Chin Huang대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (84건)
Roles of X-box binding protein 1 in liver pathogenesisYun Seok Kim, Jihoon Tak, Sang Geon Kimpp. 1-31Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screeningTian Xia, Jiawen Wangpp. 1-2KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025Eun Joo Lee, Jung Hee Kim, Byoung Kuk Jang, Miyoung Choi, Su Jong Yu, Young-Sun Lee, Young-Joo Jin, Hye Won Lee, Soon Sun Kim, Pil Soo Sung, Young Kul Jung, Gi-Ae Kim, Young Chang, Won Sohn, Jeong-ju Yoopp. 1-31Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosisHua Lu, Xiao-Song Li, Xi-Ping Shen, Hang Lipp. 3-4Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adultsDonghee Kim, Aijaz Ahmed, Won Kimpp. 5-7